Evidence map›Paper›PMID 36419169›Full record

ArticleMicrobial cell factories2022

Expression and purification of soluble recombinant β-lactamases using Escherichia coli as expression host and pET-28a as cloning vector.

Lele Li, Hui Li, Qingwu Tian, Baosheng Ge, Xiaotong Xu, Yuanyuan Chi, Huaizhi Zhao, Yanfei Liu, Nan Jia, Tingting Zhou and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Characterization of Homeodomain Proteins at the Aβ Sublocus inJournal of fungi (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Iranian journal of biotechnology · 2025
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Lele Li *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Hui Li *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Qingwu TianDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Baosheng GeState Key Laboratory of Heavy Oil Processing and Center for Bioengineering and Biotechnology, China University of Petroleum (East China), Qingdao, 266580, Shandong, China.
Xiaotong XuDepartment of Pediatric Emergency, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Yuanyuan ChiQingdao Women and Children's Hospital, Qingdao, 266034, Shandong, China.
Huaizhi ZhaoDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Yanfei LiuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Nan JiaDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Tingting ZhouDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Yuanqi ZhuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Yusun ZhouDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. zhouyusun@qdu.edu.cn.
Qingdao University · CNAffiliated Hospital of Qingdao University · CNChina University of Petroleum, East China · CNZhejiang University · CN

Funding

China Postdoctoral Science Foundation 2022M711740Natural Science Foundation of Shandong Province ZR2018BH031
6 · The paper itself

Abstract

backgroundDue to its high expression capability, recombination of Escherichia coli and pET vector has become the bioengineering preferred expression system. Because β-lactamases mediate bacterial antimicrobial resistance, these enzymes have a substantial clinical impact. Using the E. coli expression system, several kinds of β-lactamases have been produced. However, previous studies have been focused on characterizing target β-lactamases, and the effects of cultivation and induction conditions on the expression efficiency of target enzymes were not addressed.

resultsUsing pET-28a as the cloning vector and E. coli BL21(DE3) as the expression host, this study originally elucidated the effects of IPTG concentration, culture temperature, induction time, and restriction sites on recombinant β-lactamase expression. Moreover, the effects of the target protein length and the 6 × His-tag fusion position on enzyme purification were also explored, and consequently, this study yielded several important findings. (i) Only the signal peptide-detached recombinant β-lactamase could exist in a soluble form. (ii) Low-temperature induction was beneficial for soluble β-lactamase expression. (iii) The closer to the rbs the selected restriction site was, the more difficult it was to express soluble β-lactamase. (iv) The short-chain recombinant protein and the protein with His-tag fused at its C-terminus showed high affinity to the Ni

conclusionsBased on our findings, researchers can easily design an effective program for the high production of soluble recombinant β-lactamases to facilitate other related studies.

Indexed as

beta-LactamasesEscherichia coliAnti-Bacterial AgentsBioengineeringGenetic VectorsAnti-Bacterial Agentsbeta-LactamasesEscherichia coli BL21 (DE3)Protein affinity purificationRecombinant pET-28a plasmidsRecombinant β-lactamasesSoluble protein expression

Identifiers

PMID36419169
PMCPMC9686023
OpenAlexW4309884888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.